HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Robert M Califf Selected Research

sibrafiban

8/2007Use of evidence-based medicine for acute coronary syndromes in the elderly and very elderly: insights from the Sibrafiban vs aspirin to Yield Maximum Protection from ischemic Heart events postacute cOroNary sYndromes trials.
6/2006Statin use and sex-specific stroke outcomes in patients with vascular disease.
9/2005Elevated body mass index and intermediate-term clinical outcomes after acute coronary syndromes.
10/2004Postmenopausal hormone use in women with acute coronary syndromes.
9/2004Incidence and characteristics of stroke during 90-day follow-up in patients stabilized after an acute coronary syndrome.
8/2003Frequency of stent thrombosis after acute coronary syndromes (from the SYMPHONY and 2nd SYMPHONY trials).
6/2002Prognostic significance of elevated troponin I after percutaneous coronary intervention.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Robert M Califf Research Topics

Disease

125Myocardial Infarction
10/2020 - 07/2001
109Acute Coronary Syndrome
01/2019 - 07/2001
90Heart Failure
10/2020 - 01/2002
67Hemorrhage
01/2016 - 01/2002
59Stroke (Strokes)
10/2021 - 12/2002
43Atrial Fibrillation
10/2021 - 09/2003
28Cardiovascular Diseases (Cardiovascular Disease)
01/2021 - 01/2002
25Embolism (Embolus)
10/2021 - 06/2008
20Left Ventricular Dysfunction
06/2016 - 07/2002
20Unstable Angina
06/2015 - 07/2001
19ST Elevation Myocardial Infarction
02/2015 - 04/2003
18Hypertension (High Blood Pressure)
01/2018 - 01/2002
18Coronary Artery Disease (Coronary Atherosclerosis)
02/2016 - 01/2002
15Glucose Intolerance
10/2020 - 03/2007
13Infarction (Infarctions)
06/2010 - 01/2002
11Ischemia
09/2013 - 01/2002
11Thrombosis (Thrombus)
09/2010 - 08/2003
10Dyspnea (Shortness of Breath)
08/2015 - 09/2008
9Diabetes Mellitus
02/2015 - 06/2002
7Intracranial Hemorrhages (Intracranial Hemorrhage)
10/2021 - 08/2002
7Coronary Disease (Coronary Heart Disease)
02/2015 - 07/2002
7Body Weight (Weight, Body)
11/2013 - 10/2002
7Chronic Renal Insufficiency
01/2013 - 04/2008
7Renal Insufficiency (Renal Failure)
01/2013 - 04/2003
6Type 2 Diabetes Mellitus (MODY)
10/2020 - 11/2013
5Vascular Diseases (Vascular Disease)
03/2014 - 07/2003
4Chronic Obstructive Pulmonary Disease (COPD)
03/2016 - 12/2003
4Hypotension (Low Blood Pressure)
08/2015 - 03/2002
4Weight Loss (Weight Reduction)
08/2015 - 03/2006
4Anemia
03/2014 - 10/2004
4Cerebrovascular Disorders (Cerebrovascular Occlusion)
03/2014 - 07/2003
4Pathologic Constriction (Stenosis)
11/2008 - 09/2003
4Heart Arrest (Cardiac Arrest)
09/2008 - 02/2003
3Chronic Disease (Chronic Diseases)
01/2018 - 03/2006
3Cardiac Sudden Death (Sudden Cardiac Arrest)
04/2016 - 06/2005
3Peripheral Vascular Diseases (Peripheral Vascular Disease)
03/2016 - 03/2014
3Acute Kidney Injury (Acute Renal Failure)
10/2015 - 12/2010
3Sudden Death
06/2015 - 06/2005
3Weight Gain
09/2014 - 09/2013

Drug/Important Bio-Agent (IBA)

43Valsartan (Vals)FDA Link
10/2020 - 08/2003
28Brain Natriuretic Peptide (Natrecor)FDA Link
11/2019 - 11/2005
27RivaroxabanIBA
10/2021 - 06/2008
26Heparin (Liquaemin)FDA LinkGeneric
07/2012 - 07/2002
25Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
03/2014 - 03/2002
24Warfarin (Coumadin)FDA LinkGeneric
03/2016 - 05/2008
24Eptifibatide (Integrilin)FDA Link
04/2014 - 07/2001
23CreatinineIBA
03/2016 - 06/2002
21Glycoproteins (Glycoprotein)IBA
04/2014 - 01/2002
20Vitamin KFDA Link
10/2021 - 01/2013
19Enoxaparin (Lovenox)FDA LinkGeneric
07/2013 - 07/2004
18Factor Xa (Coagulation Factor Xa)IBA
10/2021 - 01/2013
17Platelet Membrane GlycoproteinsIBA
10/2007 - 07/2001
16Pharmaceutical PreparationsIBA
03/2022 - 01/2002
14Nateglinide (Starlix)FDA LinkGeneric
10/2020 - 10/2008
14Biomarkers (Surrogate Marker)IBA
01/2019 - 06/2002
11Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
01/2019 - 06/2002
11Captopril (Capoten)FDA LinkGeneric
06/2016 - 08/2003
10AnticoagulantsIBA
12/2014 - 05/2003
10StreptokinaseFDA Link
09/2013 - 07/2002
9Glucose (Dextrose)FDA LinkGeneric
10/2020 - 03/2007
9Simvastatin (Zocor)FDA LinkGeneric
01/2019 - 09/2004
9Hemoglobins (Hemoglobin)IBA
08/2016 - 03/2008
9Tirofiban (Aggrastat)FDA Link
11/2009 - 09/2002
8Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
06/2016 - 08/2002
8paragonIBA
10/2007 - 02/2002
7LipidsIBA
01/2019 - 01/2006
7NitrogenIBA
08/2015 - 07/2002
7DiureticsIBA
08/2015 - 12/2003
7Tissue Plasminogen Activator (Alteplase)FDA Link
09/2013 - 08/2002
7AntithrombinsIBA
09/2010 - 04/2003
7sibrafibanIBA
08/2007 - 06/2002
6Urea (Carbamide)FDA LinkGeneric
08/2015 - 05/2008
6Platelet Membrane Glycoprotein IIbIBA
11/2011 - 12/2002
6Creatine Kinase (Creatine Phosphokinase)IBA
11/2009 - 01/2002
6Milrinone (Primacor)FDA LinkGeneric
05/2008 - 03/2002
6TenecteplaseFDA Link
07/2005 - 04/2003
6Abciximab (ReoPro)FDA Link
03/2005 - 07/2002
5Angiotensin Receptor AntagonistsIBA
06/2016 - 11/2005
5LDL CholesterolIBA
06/2015 - 11/2008
5MB Form Creatine KinaseIBA
12/2012 - 01/2006
5Clopidogrel (Plavix)FDA Link
02/2011 - 01/2007
5Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA
10/2008 - 08/2002
4Ezetimibe (Zetia)FDA Link
01/2019 - 08/2014
4Amiodarone (Amiodarona)FDA LinkGeneric
06/2014 - 01/2008
4Antihypertensive Agents (Antihypertensives)IBA
06/2014 - 08/2006
4TroponinIBA
07/2013 - 02/2007
3Simvastatin Drug Combination Ezetimibe (Vytorin)FDA Link
01/2019 - 11/2008
3PotassiumIBA
09/2014 - 02/2003

Therapy/Procedure

113Therapeutics
10/2020 - 07/2001
31Percutaneous Coronary Intervention
03/2014 - 06/2002
28Coronary Artery Bypass (Coronary Artery Bypass Surgery)
03/2014 - 01/2002
13Thrombolytic Therapy
09/2013 - 02/2002
12Patient Readmission
08/2015 - 11/2005
9Blood Transfusion (Blood Transfusions)
07/2013 - 07/2004
7Secondary Prevention
02/2010 - 06/2002
6Length of Stay
01/2015 - 02/2004
5Catheters
09/2010 - 05/2005
4Stents
11/2012 - 08/2003
3Surgical Amputation (Amputations)
08/2016 - 09/2010
3Critical Care (Surgical Intensive Care)
12/2014 - 10/2004